An analysis of hematurias medication usage among Canadians

An analysis by the Canadian Centre for Policy Alternatives has found that patients who use hematuriasis medication are more likely to be prescribed other medications.The analysis found that in 2017, 4.5 million Canadians were taking the treatment.The majority of patients who are taking the medication are aged 65 and over, and are in the country